Compare DAVE & TWST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DAVE | TWST |
|---|---|---|
| Founded | 2017 | 2013 |
| Country | United States | United States |
| Employees | 280 | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 5.2B |
| IPO Year | N/A | 2018 |
| Metric | DAVE | TWST |
|---|---|---|
| Price | $400.87 | $90.99 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 8 |
| Target Price | ★ $312.75 | $46.88 |
| AVG Volume (30 Days) | 605.1K | ★ 2.2M |
| Earning Date | 05-05-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 63.89 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $376,572,000.00 |
| Revenue This Year | $26.28 | $18.91 |
| Revenue Next Year | $17.38 | $15.07 |
| P/E Ratio | $17.85 | ★ N/A |
| Revenue Growth | N/A | ★ 20.32 |
| 52 Week Low | $152.21 | $23.30 |
| 52 Week High | $409.00 | $105.47 |
| Indicator | DAVE | TWST |
|---|---|---|
| Relative Strength Index (RSI) | 73.61 | 56.55 |
| Support Level | $231.19 | $42.88 |
| Resistance Level | N/A | $105.47 |
| Average True Range (ATR) | 22.85 | 6.98 |
| MACD | 3.22 | -1.42 |
| Stochastic Oscillator | 91.78 | 40.43 |
Dave Inc is a financial services company. It is engaged in offering banking app that offers its customers banking, financial insights, overdraft protection, building credit, short-term liquidity, fee-free banking, and financial management tools, and finding side gigs.
Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.